Evidence map›Paper›PMID 33929711›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.

Elisabet Ampudia-Mesias, Francisco Puerta-Martinez, Miurel Bridges, David Zellmer, Andrew Janeiro, Matt Strokes, Yuk Y Sham, Ayman Taher, Maria G Castro, Christopher L Moertel and 2 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Elisabet Ampudia-MesiasDepartment of Pediatrics, University of Minnesota, Minneapolis, MN, 55455, USA.
Francisco Puerta-MartinezDepartment of Molecular and Computational Biology, University of Southern California, Los Angeles, CA, 90089, USA.
Miurel BridgesBioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, MN, 55455, USA.
David ZellmerDepartment of Pediatrics, University of Minnesota, Minneapolis, MN, 55455, USA.
Andrew JaneiroDepartment of Molecular and Computational Biology, University of Southern California, Los Angeles, CA, 90089, USA.
Matt StrokesCell Signaling Technology, Inc, Danvers, MA, 09123, USA.
Yuk Y ShamBioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, MN, 55455, USA.
Ayman TaherDepartment of Neurosurgery and Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Maria G CastroDepartment of Neurosurgery and Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
Christopher L MoertelDepartment of Pediatrics, University of Minnesota, Minneapolis, MN, 55455, USA.
G Elizabeth PluharMasonic Cancer Center, University of Minnesota, Minneapolis, MN, 55455, USA.
Michael R OlinDepartment of Pediatrics, University of Minnesota, Minneapolis, MN, 55455, USA. olin0012@umn.edu.
University of Minnesota · USUniversity of Michigan–Ann Arbor · USUniversity of Minnesota Medical Center · USUniversity of Southern California · USCell Signaling Technology (United States) · US

Funding

Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
NIDA NIH HHS T32 DA007097
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33929711
PMCPMC8608986
OpenAlexW3159128401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.